Erklärung zur Barrierefreiheit Navigation überspringen
  • Zurück zu Global Sites
  • +44 (0)20 7454 5110
  • DSGVO
  • Journalisten
  • Weitere Informationen anfordern
PR Newswire: news distribution, targeting and monitoring
  • Nachrichten
  • Produkte
  • Kontakt
When typing in this field, a list of search results will appear and be automatically updated as you type.

Suche nach Ihrem Inhalt...

Keine Ergebnisse gefunden. Bitte verwenden Sie die erweiterte Suche, um den vollständigen Inhalt zu überprüfen.
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Weitere Informationen anfordern
    • Telefon

    • +44 (0)20 7454 5110 von 8 AM - 5 PM GMT

    • Kontakt
    • Kontakt

      +44 (0)20 7454 5110
      von 8 AM - 5 PM GMT

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Weitere Informationen anfordern
  • Journalisten
  • DSGVO
  • Weitere Informationen anfordern
  • Journalisten
  • DSGVO
  • Weitere Informationen anfordern
  • Journalisten
  • DSGVO
  • Weitere Informationen anfordern
  • Journalisten
  • DSGVO

Natus expands availability to expert-level review of EEG with global launch of autoSCORE AI analysis tool
  • France - Français
  • Deutschland - Deutsch
  • Italia - Italiano
  • USA - English

Natus Color Logo

Vom Nachrichtendienst

Natus Medical Incorporated

05 März, 2026, 15:23 GMT

Artikel teilen

Share toX

Artikel teilen

Share toX

MIDDLETON, Wis., March 5, 2026 /PRNewswire/ -- Natus Medical Incorporated has announced the global launch of the autoSCORE™ analysis tool, spreading the availability of the first artificial-intelligence model capable of automatic and comprehensive clinical EEG interpretations while providing accuracy on par with medical experts.

Natus Neuro CEO Chris Landon announces the global launch of their autoSCORE analysis tool, the first AI model capable of interpreting clinical EEGs at the level of the world’s top experts.
Natus Neuro CEO Chris Landon announces the global launch of their autoSCORE analysis tool, the first AI model capable of interpreting clinical EEGs at the level of the world’s top experts.
Speed
Speed
Dr. Ram Mohan Sankaraneni declares the Natus autoSCORE analysis tool a powerful pathway to faster interventions.
Dr. Ram Mohan Sankaraneni declares the Natus autoSCORE analysis tool a powerful pathway to faster interventions.

With its introduction to the United States market in August 2024 for routine EEG studies, U.S. neuro care teams became the first to experience the benefits of autoSCORE, which alleviated the demands on clinical resources and staff through a deep-learning model developed in Norway by Holberg EEG and trained on 30,000 expertly labeled EEG recordings. Offered exclusively with Natus NeuroWorks software, autoSCORE is FDA 510(k) cleared for an expanded indication to include routine EEG, LTM and Ambulatory EEG studies. It has also received the CE mark for European and other international markets.

"Developing the first AI model capable of interpreting clinical EEGs at the level of the world's top experts marks a defining moment for both Natus and the field of neurodiagnostics," said Chris Landon, CEO of Natus Neuro. "Now, we're proud to bring this breakthrough innovation to healthcare providers globally – advancing our mission to expand patient access and deliver life-changing outcomes through cutting-edge neuro solutions."

Early adopters welcomed the confidence provided by the ability of autoSCORE to go beyond traditional spike and seizure detectors, assessing multiple clinically relevant abnormalities and providing study-level assessments to inform healthcare providers if an EEG study is normal or abnormal. They also found comfort in its closed AI model, which ensures consistency and security.

"Human teaming with intelligent machines has become a fundamental characteristic of a successful clinical decision support system," said Dr. Ram Mohan Sankaraneni, a board-certified neurologist and fellow of the American Epilepsy Society and the American Academy of Neurology. "(autoSCORE) is a reliable colleague that can provide a second opinion... a powerful pathway to faster interventions."

Visual EEG review is considered the gold standard for determining abnormalities, but it can strain department resources. The AI-enabled autoSCORE application is designed to allow teams to more efficiently and consistently perform EEG data analysis.

ABOUT NATUS

Natus is trusted by healthcare providers around the globe as the solution source to screen, diagnose, and treat disorders affecting the brain and neural pathways. The best-in-class Natus solutions, including service, field support and education, enable clinicians to advance their standard of care, improving patient outcomes and quality of life. For more information on Natus, visit natus.com/neuro.

CONTACT INFORMATION:
Lisa Schuler
Phone: +1 612 528-1332
Email: [email protected]

Video - https://mma.prnewswire.com/media/2926890/autoSCORE_Global_Chris_Landon.mp4 
Photo - https://mma.prnewswire.com/media/2926889/autoSCORE_Sankaraneni_Quote.jpg 
Logo - https://mma.prnewswire.com/media/2477077/5838090/Natus_Logo.jpg

Modal title

Mehr von dieser Quelle

Natus erweitert die Verfügbarkeit von EEG-Auswertungen auf Expertenniveau mit der weltweiten Einführung des KI-Analyse-Tools autoSCORE

Natus erweitert die Verfügbarkeit von EEG-Auswertungen auf Expertenniveau mit der weltweiten Einführung des KI-Analyse-Tools autoSCORE

Natus Medical Incorporated hat die weltweite Markteinführung des Analyse-Tools autoSCORE™ bekannt gegeben. Damit wird das erste KI-Modell verfügbar,...

Natus stellt mit der Einführung der neuesten Version der Natus-Elite-Software die Innovation AVEMG vor

Natus stellt mit der Einführung der neuesten Version der Natus-Elite-Software die Innovation AVEMG vor

Natus Medical Incorporated gibt die Einführung der neuesten Version seiner branchenführenden EMG-Software Natus Elite bekannt. Diese Version bietet...

Weitere Pressemitteilungen von dieser Quelle

Suchen

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

Banking & Financial Services

Banking & Financial Services

Pressemeldungen zu ähnlichen Themen

Kontaktaufnahme zu PR Newswire

  • +44 (0)20 7454 5110
    von 8 AM - 5 PM GMT

Globale Seiten

  • APAC
  • APAC – Traditionelles Chinesisch
  • Asien
  • Brasilien
  • Kanada
  • Tschechische Republik
  • Dänemark
  • Finnland
  • Frankreich
  • Deutschland

 

  • Indien
  • Indonesia
  • Israel
  • Italien
  • Mexiko
  • Naher Osten
  • Naher Osten – Arabisch
  • Niederlande
  • Norwegen
  • Polen

 

  • Portugal
  • Russland
  • Slowakei
  • Spanien
  • Schweden
  • Großbritannien
  • Vereinigte Staaten

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Globale Seiten
  • Asien
  • Brasilien
  • Kanada
  • Tschechische Republik
  • Dänemark
  • Finnland
  • Frankreich
  • Deutschland
  • Indien
  • Israel
  • Italien
  • Mexiko
  • Naher Osten
  • Niederlande
  • Norwegen
  • Polen
  • Portugal
  • Russland
  • Slowakei
  • Spanien
  • Schweden
  • Großbritannien
  • Vereinigte Staaten
+44 (0)20 7454 5110
von 8 AM - 5 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.